Skip to main content

Table 1 The laboratory data, initial and 2 years after

From: Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report

Hematology (initial) Biochemistry (initial)
WBC 18,100 /μL TP 6.9 g/dL CEA 2.6 ng/mL
Neut 69.5 % Alb 2.8 g/dL SCC 0.9 ng/mL
Eos 16 % AST 9 U/L NSE 10.3 ng/mL
Lym 11 % ALT 16 U/L ProGRP 33.9 pg/mL
Hb 8.9 g/dL LDH 192 U/L CYFRA 1.6 ng/mL
Ht 27.2 % ALP 522 U/L CA19–9 5 U/mL
MCV 86.3 μm3 γ-GTP 79 U/L sIL-2R 10,252 U/mL
MCHC 32.7 % CK 16 U/L HTLV-1 antibody < 16 times
Plt 375,000 /μL Na 138 mEq/L T-SPOT® (−)  
ESR 136 mm/h K 4.5 mEq/L QuantiFERON® < 0.05  
    Cl 102 mEq/L    undeterminate
(2 years after)   BUN 23 mg/dL Capillia MAC IgA® (−)  
    CRE 0.93 mg/dL IgG 1072 mg/dL
WBC 7400 /μL Blood Sugar 106 mg/dL IgA 144 mg/dL
Lym 20.4 % CRP 7.56 mg/dL IgM 61 mg/dL
CD4 30.7 % PCT 0.43 ng/mL HIV-1/2 antibodies (−/−)  
CD8 39.7 % β-D glucan < 2.4 pg/mL    
CD4/CD8 0.8      PHA SI 528.4  
  1. PCT procalcitonin, CEA carcinoembryonic antigen, SCC Squamous Cell Carcinoma, CYFRA cytokeratin 19 fragment, NSE nerve specific enolase, Pro GRP pro-gastrin releasing peptide, CA19–9 carbohydrate antigen 19–9, sIL-2R soluble interleukin-2 receptor, PHA SI the lymphocyte phytohemagglutinin (PHA) stimulation index